The Journal of Association of Chest Physicians

REVIEW ARTICLE
Year
: 2020  |  Volume : 8  |  Issue : 2  |  Page : 48--52

Nintedanib for the treatment of idiopathic pulmonary fibrosis: An Indian perspective


Anubhuti Singh1, Kislay Kishore2, Ajay K Verma3, Arpita Singh4 
1 Department of Respiratory Medicine, Shri Guru Ram Rai Institute of Medical and Health Sciences, Dehradun, Uttarakhand, India
2 Department of Respiratory Medicine, Base Hospital Delhi Cantt, Delhi, India
3 Department of Respiratory Medicine, King George Medical University, Lucknow, Uttar Pradesh, India
4 Department of Pharmacology, Dr Ram Manohar Lohia Institute of Medical Sciences, Gomti Nagar, Lucknow, Uttar Pradesh, India

Correspondence Address:
Dr. Kislay Kishore
MD, Graded Specialist (Respiratory Medicine), Department of Respiratory Medicine, Base Hospital, Delhi Cantt, Delhi 110010
India

Idiopathic pulmonary fibrosis (IPF) is a chronic disease associated with progressive deterioration of lung function and ultimately death. Until recent past, no drug therapy was approved for the management of IPF and patients either received symptomatic treatment or were enrolled in clinical trials. Since 2014, two new drugs with anti-fibrotic potential have been approved following positive outcomes in large-scale clinical trials. Nintedanib is the latest drug in this category and has recently been launched in India. Here we present a review about nintedanib, covering its mechanism of action, efficacy, adverse effect profile, cost effectiveness and implications in the Indian setting.


How to cite this article:
Singh A, Kishore K, Verma AK, Singh A. Nintedanib for the treatment of idiopathic pulmonary fibrosis: An Indian perspective.J Assoc Chest Physicians 2020;8:48-52


How to cite this URL:
Singh A, Kishore K, Verma AK, Singh A. Nintedanib for the treatment of idiopathic pulmonary fibrosis: An Indian perspective. J Assoc Chest Physicians [serial online] 2020 [cited 2020 Sep 22 ];8:48-52
Available from: http://www.jacpjournal.org/article.asp?issn=2320-8775;year=2020;volume=8;issue=2;spage=48;epage=52;aulast=Singh;type=0